CompaniesOstial Corporation

Ostial Corporation

active

Campbell, CA, United States

Founded 2010

Website

About

Dual-balloon Stent

Areas of Focus

Categories

Medical ImplantUncategorized Medical DeviceBiotech

Clinical Trials (157)

View all

Total Trials

157

As Lead Sponsor

As Collaborator

Total Enrollment

81,455

By Phase

NA: 72PHASE4: 9PHASE2: 13EARLY_PHASE1: 1PHASE1: 14PHASE3: 5PHASE1/PHASE2: 2PHASE2/PHASE3: 2

By Status

COMPLETED: 97RECRUITING: 18TERMINATED: 18UNKNOWN: 8ACTIVE_NOT_RECRUITING: 5WITHDRAWN: 4NOT_YET_RECRUITING: 3ENROLLING_BY_INVITATION: 2SUSPENDED: 2

Clinical Trials Pipeline154 trials

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

1995

1996

1997

1998

1999

2000

2001

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

2026

2027

2028

2029

2030

2031

2032

2033

2034

2035

2036

Today

NCT00475449

The Stent or Surgery (SoS) Trial

Phase: N/A

Role: Collaborator

Start: Nov 30, 1996

Completion: Feb 28, 2006

NCT00475449

NCT00180570

SALT - Success of Active Versus Passive Lead Fixation of Atrial Pacing/Sensing Electrodes

Phase: Phase 4

Role: Lead Sponsor

Start: Jan 31, 1997

Completion: Jan 31, 2006

NCT00180570

NCT00180427

"VERRARI - Are Ventricular Arrhythmic Episodes Reduced by Rate Response in ICDs?"

Phase: Phase 4

Role: Lead Sponsor

Start: Jun 30, 2001

Completion: Nov 30, 2004

NCT00848835

Long Term Integrity Follow-up Evaluation

Phase: N/A

Role: Lead Sponsor

Start: Mar 31, 2002

Completion: Jan 31, 2010

NCT00848835

NCT00180401

MODULA-Study: Modul 10: Benefit of CRT-Therapy in CRT-Patients With QRS-Complex of 120 - 150 Ms

Phase: N/A

Role: Collaborator

Start: Jun 30, 2002

Completion: Oct 31, 2007

NCT00180440

INSURE: INcidence Free SUrvival Before and After Implantable Cardioverter Defibrillator (ICD) Replacement

Phase: N/A

Role: Lead Sponsor

Start: Jul 31, 2002

Completion: Nov 30, 2008

NCT00180440

NCT00192972

A Randomized Trial of the Ostial Versus the Extra-Ostial Ablation Strategy for Atrial Fibrillation

Phase: N/A

Role: Collaborator

Start: Nov 30, 2002

Completion: Jun 30, 2005

NCT00273091

MODULA Modul 5 BEAT-HF

Phase: N/A

Role: Collaborator

Start: Aug 31, 2003

Completion: May 31, 2007

NCT00180557

Austria Study - Analysis of Difference Between Active and Passive Fixation Leads

Phase: Phase 4

Role: Lead Sponsor

Start: Sep 30, 2003

Completion: May 31, 2007

NCT00180609

SCANCAP Scandinavian Automatic Capture Study

Phase: N/A

Role: Lead Sponsor

Start: Dec 31, 2003

Completion: Jul 31, 2006

NCT00180531

Monitoring of Arrhythmias and HRV in Patients With Heart Failure Treated With the CRT Pacemaker Renewal TR2

Phase: Phase 4

Role: Lead Sponsor

Start: Feb 29, 2004

Completion: Jun 30, 2007

NCT00116792

PROVIDENCE:Prevention of Restenosis With Oral Rosiglitazone and the Vision Stent in Diabetics With Coronary Lesions

Phase: Phase 2/3

Role: Collaborator

Start: Mar 31, 2004

Completion: Not specified

NCT00116792

NCT00279175

REPAIR-AMI: Intracoronary Progenitor Cells in Acute Myocardial Infarction (AMI)

Phase: Phase 3

Role: Collaborator

Start: Apr 30, 2004

Completion: Dec 31, 2010

NCT00279175

NCT00180362

Quick ICD Study: Is Extensive Electrophysiological Testing Before, During and After ICD-Implantation Still Necessary ?

Phase: Phase 4

Role: Collaborator

Start: May 31, 2004

Completion: Sep 30, 2004

NCT00164190

Routine Angioplasty and Stenting After Fibrinolysis for Acute Myocardial Infarction

Phase: N/A

Role: Collaborator

Start: Jul 31, 2004

Completion: Jan 31, 2009

NCT00180414

MODULA Modul 7 VRR

Phase: N/A

Role: Collaborator

Start: Aug 28, 2004

Completion: May 7, 2008

NCT00158015

Prospective Minnesota Study of ECHO Tissue Doppler Imaging in Cardiac Resynchronization Therapy

Phase: N/A

Role: Collaborator

Start: Oct 31, 2004

Completion: Sep 30, 2007

NCT00180492

Post-Approval Study of the Guidant Carotid Stent Systems and Embolic Protection Systems: CAPTURE

Phase: N/A

Role: Collaborator

Start: Oct 31, 2004

Completion: Aug 31, 2007

NCT00848653

ELECTION - The Electrode Configuration Cardiac Resynchronization Therapy (CRT) Study (ELECTION)

Phase: N/A

Role: Lead Sponsor

Start: Nov 30, 2004

Completion: Dec 31, 2008

NCT00180297

Septal - Success Rate and Clinical Outcome of Septal Implant of Ventricular Defibrillation Lead

Phase: N/A

Role: Collaborator

Start: Apr 30, 2005

Completion: Sep 30, 2012

NCT00180297

NCT00257309

Thrombolysis Versus Primary Angioplasty for AMI in Elderly Patients

Phase: Phase 4

Role: Collaborator

Start: Apr 30, 2005

Completion: Dec 31, 2008

NCT00245245

Study of Recombinant Porcine Factor VIII (FVIII) in Hemophilia and Inhibitors to FVIII

Phase: Phase 2

Role: Lead Sponsor

Start: May 31, 2005

Completion: Jun 30, 2007

NCT00848341

Canadian Registry of ICD Implant Testing Procedures

Phase: N/A

Role: Lead Sponsor

Start: Jan 31, 2006

Completion: Nov 30, 2008

NCT00292539

Prospective Registry of Pacemaker Patients Concerning Percentage of Right Ventricular Pacing, LVEF and NYHA Class

Phase: N/A

Role: Lead Sponsor

Start: Feb 28, 2006

Completion: Sep 30, 2006

NCT00305526

REBEAT Resynchronisation and Beta-Blocker European Trial

Phase: Phase 4

Role: Lead Sponsor

Start: Apr 30, 2006

Completion: Jul 31, 2007

NCT00335036

Pediatric Lead Extractability and Survival Evaluation (PLEASE)

Phase: N/A

Role: Collaborator

Start: Jun 30, 2006

Completion: Jan 31, 2009

NCT00720642

Percutaneous Excision Trial

Phase: N/A

Role: Lead Sponsor

Start: Jul 31, 2006

Completion: Jun 30, 2011

NCT00409604

PROTECT : Pacing to Protect Heart for Damage From Blocked Heart Vessel and From Re-opening Blocked Vessel(s)

Phase: Phase 2

Role: Lead Sponsor

Start: Dec 31, 2006

Completion: Aug 31, 2009

NCT00758303

A Study to Evaluate the Lipid Regulating Effects of TRIA-662

Phase: Phase 2/3

Role: Lead Sponsor

Start: Sep 30, 2007

Completion: Dec 31, 2008

NCT01930240

The Safety of a Hypolipidemic Agent in Healthy Normal Volunteers

Phase: Phase 1

Role: Lead Sponsor

Start: Nov 30, 2007

Completion: Jan 31, 2008

NCT00569140

A Phase 1, Safety, Tolerability and Pharmacokinetic Profile of Intravitreous Injections of E10030 (Anti-PDGF Pegylated Aptamer) in Subjects With Neovascular Age-Related Macular Degeneration

Phase: Phase 1

Role: Lead Sponsor

Start: Dec 31, 2007

Completion: Dec 31, 2008

NCT00606710

Cognis and Teligen 100 HE and Reliance Quadripolar Defibrillation Lead (4-Site) Field Following

Phase: N/A

Role: Lead Sponsor

Start: Feb 29, 2008

Completion: Oct 31, 2008

NCT00838721

Evaluation of Pascal Laser Trabeculoplaty

Phase: N/A

Role: Collaborator

Start: Mar 31, 2008

Completion: Mar 31, 2010

NCT00679744

A Phase I Study of Pyrimethamine in Patients With GM2 Gangliosidosis

Phase: Phase 1

Role: Lead Sponsor

Start: May 31, 2008

Completion: Not specified

NCT00679744

NCT00711893

Feature Assessment Study for Indications Based Programming

Phase: N/A

Role: Collaborator

Start: Jun 30, 2008

Completion: Feb 28, 2010

NCT00728182

Evaluating Neuroprotection in Aneurysm Coiling Therapy

Phase: Phase 2

Role: Collaborator

Start: Aug 31, 2008

Completion: May 31, 2011

NCT00709527

ARC1905 (Anti-C5 Aptamer) Given With Lucentis 0.5 mg In People With Neovascular Age-Related Macular Degeneration

Phase: Phase 1

Role: Lead Sponsor

Start: Oct 16, 2008

Completion: Dec 30, 2009

NCT00782093

A Phase 1 Ascending and Parallel Group Trial to Establish the Safety, Tolerability and Pharmacokinetics Profile of Volociximab (Alpha 5 Beta 1 Integrin Antagonist) in Subjects With Neovascular Age- Related Macular Degeneration

Phase: Phase 1

Role: Lead Sponsor

Start: Oct 31, 2008

Completion: Jun 30, 2012

NCT00833352

Comparison of Right Ventricular Septal and Right Ventricular Apical Pacing in Patients Receiving a CRT-D Device

Phase: N/A

Role: Lead Sponsor

Start: Nov 30, 2008

Completion: Dec 31, 2011

NCT01105572

Aetna_Intel Medicare Home Biomonitoring Study

Phase: N/A

Role: Collaborator

Start: Nov 30, 2008

Completion: Apr 30, 2010

NCT00833014

Dynamic Annuloplasty System With Activation for the Treatment of Mitral Regurgitation

Phase: Phase 2

Role: Lead Sponsor

Start: Dec 31, 2008

Completion: Dec 31, 2010

NCT00800384

Shockless Implant Evaluation

Phase: N/A

Role: Collaborator

Start: Jan 31, 2009

Completion: May 31, 2014

NCT00920452

The 4-SITE Field Following Study (4-SITE FF)

Phase: N/A

Role: Lead Sponsor

Start: May 31, 2009

Completion: Jan 31, 2011

NCT00950638

A Study of ARC1905 (Anti-C5 Aptamer) in Subjects With Dry Age-related Macular Degeneration

Phase: Phase 1

Role: Lead Sponsor

Start: Jul 16, 2009

Completion: Mar 24, 2011

NCT01418703

Feasibility Study of a Modular Control to Range System in Type 1 Diabetes Mellitus

Phase: N/A

Role: Collaborator

Start: Oct 31, 2009

Completion: Dec 31, 2010

NCT01076049

The Effect of Irrisept for Irrigation of Skin and Soft Tissue Infections (Irrisept USF Study)

Phase: N/A

Role: Lead Sponsor

Start: Jan 31, 2010

Completion: Dec 31, 2011

NCT04957732

The Effect of Wound Irrigation With Irrisept on Abscess Healing (Irrisept UF Study)

Phase: N/A

Role: Lead Sponsor

Start: Jan 31, 2010

Completion: Nov 30, 2011

NCT01390259

Hypoglycemia Prevention After Exercise in Adolescent T1DM Patients Using a Control to Range System

Phase: N/A

Role: Collaborator

Start: Jan 31, 2010

Completion: Feb 28, 2011

NCT01043406

Seizure Advisory System Feasibility Study

Phase: Phase 1

Role: Lead Sponsor

Start: Mar 31, 2010

Completion: Oct 31, 2012

NCT01089517

A Safety and Efficacy Study of E10030 (Anti-PDGF Pegylated Aptamer) Plus Lucentis for Neovascular Age-Related Macular Degeneration

Phase: Phase 2

Role: Lead Sponsor

Start: Mar 31, 2010

Completion: Jun 30, 2012

NCT01147965

Active Immunotherapy CEA Vaccine in Patients With Malignancies Expressing CEA

Phase: Phase 1/2

Role: Lead Sponsor

Start: Jun 30, 2010

Completion: Mar 31, 2013

NCT01275846

Deployment of American Heart Association Heart Failure Protocols and Content Within the Intel® Health Guide System

Phase: N/A

Role: Collaborator

Start: Jun 30, 2010

Completion: Mar 31, 2011

NCT01143220

Japanese Assessment of Indication Based Programming

Phase: N/A

Role: Collaborator

Start: Aug 31, 2010

Completion: Sep 30, 2012

NCT01227785

Next Generation INCEPTA Implantable Cardioverter Defibrillator (ICD) and Cardiac Resynchronization Therapy (CRT-D) Field Following Study

Phase: N/A

Role: Lead Sponsor

Start: Oct 31, 2010

Completion: Dec 31, 2011

NCT01302548

The Effect Of Wound Irrigation With Irrisept™ Delivery System On Abscess Healing In Patients Presenting To The Emergency Department

Phase: N/A

Role: Collaborator

Start: Feb 28, 2011

Completion: Aug 31, 2012

NCT01555840

Comparative Study of the Magnetically Guided Capsule Endoscopy Versus High Definition Gastroscopy

Phase: N/A

Role: Collaborator

Start: Nov 30, 2011

Completion: Jun 30, 2012

NCT01582139

Feasibility Study of Closed Loop Control in Type 1 Diabetes Using Heart Rate Monitoring as an Exercise Marker

Phase: N/A

Role: Collaborator

Start: May 31, 2012

Completion: Aug 31, 2012

NCT01600664

"The Effect of the Use of Computer Game- My Diabetic Friend in Children With Type 1 Diabetes"

Phase: N/A

Role: Collaborator

Start: Jun 30, 2012

Completion: Aug 31, 2013

NCT01648504

Johns Hopkins Interactive eGuide to Colonoscopy and Ipad Office Education to Improve Colonoscopy

Phase: N/A

Role: Collaborator

Start: Jun 30, 2012

Completion: Sep 30, 2013

NCT01776190

Low-dose UVA1 Radiation in Cutaneous Lupus Patients

Phase: N/A

Role: Collaborator

Start: Sep 30, 2012

Completion: Sep 30, 2022

NCT01776190

NCT01699698

Pancreatic Juice Diagnosis From Duodenum

Phase: N/A

Role: Lead Sponsor

Start: Oct 31, 2012

Completion: Not specified

NCT01699698

NCT01463215

Clinical Trial of Ambroxol in Patients With Type I Gaucher Disease

Phase: Phase 1/2

Role: Lead Sponsor

Start: Dec 31, 2012

Completion: Aug 31, 2015

NCT01753479

Spectroscopy From Duodenum

Phase: N/A

Role: Lead Sponsor

Start: Jan 31, 2013

Completion: Jun 30, 2016

NCT01809301

Comparison of TRIA-662 500 mg and Niaspan 1000 mg in Healthy Male and Female Volunteers Under Fed Conditions

Phase: Phase 1

Role: Lead Sponsor

Start: Mar 31, 2013

Completion: May 31, 2013

NCT01940900

A Phase 3 Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Lucentis® Compared to Lucentis® Monotherapy

Phase: Phase 3

Role: Lead Sponsor

Start: Aug 31, 2013

Completion: Dec 31, 2016

NCT01944839

A Phase 3 Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Lucentis® Compared to Lucentis® Monotherapy

Phase: Phase 3

Role: Lead Sponsor

Start: Aug 31, 2013

Completion: Dec 31, 2016

NCT01989182

The Spiration Valve System for the Treatment of Severe Emphysema

Phase: N/A

Role: Collaborator

Start: Nov 8, 2013

Completion: Mar 31, 2017

NCT02008084

A Pilot Study to Evaluate the Lipid Effects of TRIA-662

Phase: Phase 2

Role: Lead Sponsor

Start: Dec 31, 2013

Completion: Oct 31, 2015

NCT02591914

An Open-Label Investigator Sponsored Trial to Investigate the Safety, Tolerability and Development of Subfoveal Fibrosis By Intravitreal Administration of Altering Regimens of Fovista and Anti-VEGF Therapy in Subjects With Neovascular Age-Related Macular Degeneration

Phase: Phase 1

Role: Collaborator

Start: Feb 28, 2014

Completion: May 24, 2016

NCT01940887

A Phase 3 Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Either Avastin® or Eylea® Compared to Avastin® or Eylea® Monotherapy

Phase: Phase 3

Role: Lead Sponsor

Start: May 31, 2014

Completion: Sep 30, 2017

NCT02156557

Study of KCC Peptide Application in the Colon

Phase: Phase 1

Role: Collaborator

Start: Jun 30, 2014

Completion: Aug 31, 2016

NCT02214628

Phase 2A Open Label Safety Study of Fovista® (Anti-PDGF BB) Regimen Administered in Combination With Anti-VEGF Therapy to Study Sub-Retinal Fibrosis in Neovascular AMD

Phase: Phase 2

Role: Lead Sponsor

Start: Jul 31, 2014

Completion: Dec 31, 2016

NCT02252757

Assess Measurements of Wireless Cardiac Output Device

Phase: N/A

Role: Collaborator

Start: Sep 30, 2014

Completion: Sep 30, 2014

NCT02315456

Evaluation of Centration of Intraocular Lens With Two Settings for Capsulorhexis With Femtosecond Laser

Phase: N/A

Role: Collaborator

Start: Dec 31, 2014

Completion: Aug 9, 2016

NCT02255487

Irrisept Versus Standard of Care in the Prevention of Surgical Site Infections

Phase: N/A

Role: Lead Sponsor

Start: Feb 18, 2015

Completion: Mar 13, 2017

NCT02397954

A Study to Establish the Safety and Tolerability of Zimura™ (Anti-C5 Aptamer) in Combination With Anti-VEGF Therapy in Subjects With Idiopathic Polypoidal Choroidal Vasculopathy (IPCV)

Phase: Phase 2

Role: Lead Sponsor

Start: Mar 12, 2015

Completion: Oct 23, 2015

NCT02418962

Safety and Immunogenicity of Direct Venous Inoculation of a Radiation-attenuated PfSPZ Vaccine in Equatoguinean Adults

Phase: Phase 1

Role: Collaborator

Start: Mar 31, 2015

Completion: Feb 29, 2016

NCT02442830

Comparing Early Capsule Deployment to Current Standard of Care for Management of Gastrointestinal Bleeding

Phase: N/A

Role: Collaborator

Start: Apr 19, 2015

Completion: Jul 2, 2017

NCT02769780

A Web-based Observational Study of Patient-reported Outcomes in Adults With Narcolepsy

Phase: N/A

Role: Collaborator

Start: Jul 8, 2015

Completion: Aug 9, 2021

NCT02474329

Real-PD Trial: Development of Clinical Prognostic Models for Parkinson's Disease

Phase: N/A

Role: Collaborator

Start: Jul 31, 2015

Completion: Nov 30, 2016

NCT02470052

A Prospective Multicenter Clinical Study to Evaluate the Safety and Effectiveness of the OL-BF-001 for Severe Emphysema

Phase: N/A

Role: Lead Sponsor

Start: Aug 31, 2015

Completion: Aug 31, 2018

NCT02561078

An Administration Method Study of Human Regular U-500 Insulin (LY041001) in Participants With Type 2 Diabetes Mellitus

Phase: Phase 3

Role: Collaborator

Start: Oct 20, 2015

Completion: May 9, 2017

NCT02668835

GADGET-PD Genetic and Digital Diagnosis of Essential Tremor and Parkinson's Disease Trial

Phase: N/A

Role: Collaborator

Start: Nov 30, 2015

Completion: Apr 30, 2019

NCT02613520

Safety and Immunogenicity in Age De-Escalation of PfSPZ Vaccine in Tanzanian Adults, Children, and Infants

Phase: Phase 1

Role: Collaborator

Start: Dec 31, 2015

Completion: Mar 31, 2017

NCT03996304

Health and Early Life Microbiota

Phase: N/A

Role: Collaborator

Start: Feb 26, 2016

Completion: Aug 31, 2020

NCT02387957

A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)

Phase: Phase 2

Role: Lead Sponsor

Start: Apr 26, 2016

Completion: Jan 31, 2017

NCT02592837

EBUS-TBNA vs Flex 19G EBUS-TBNA

Phase: N/A

Role: Collaborator

Start: May 31, 2016

Completion: Dec 14, 2017

NCT02897557

Insulet Artificial Pancreas Early Feasibility Study

Phase: N/A

Role: Lead Sponsor

Start: Sep 30, 2016

Completion: Mar 31, 2017

NCT02916459

EBUS-TBNA vs Flex 19G EBUS-TBNA

Phase: N/A

Role: Collaborator

Start: Oct 31, 2016

Completion: Oct 31, 2018

NCT02859350

Safety, Tolerability and Immunogenicity of PfSPZ Vaccine in an Age De-escalation Trial in Equatorial Guinea.

Phase: Phase 1

Role: Collaborator

Start: Nov 30, 2016

Completion: Feb 28, 2018

NCT03064906

Insulet Artificial Pancreas Evaluating Meal Performance and Moderate Exercise (IDE2)

Phase: N/A

Role: Lead Sponsor

Start: Mar 18, 2017

Completion: Apr 7, 2017

NCT03193255

Efficacy and Safety of cleadewGP for Rigid Contact Lenses

Phase: N/A

Role: Collaborator

Start: Jun 14, 2017

Completion: Aug 1, 2019

NCT03362190

ZIMURA in Combination With LUCENTIS in Patients With Neovascular Age Related Macular Degeneration (NVAMD)

Phase: Phase 2

Role: Lead Sponsor

Start: Oct 11, 2017

Completion: Oct 18, 2018

NCT06330714

Remote Monitoring of Chronic Illness Patients With a IHAP Home Wireless Hub and Vitals Measurements

Phase: N/A

Role: Collaborator

Start: Jul 1, 2018

Completion: Dec 30, 2018

NCT03590340

Regimen Optimization Trial of PfSPZ Vaccine in Equatorial Guinea

Phase: Phase 1

Role: Collaborator

Start: Jul 30, 2018

Completion: Mar 12, 2019

NCT03647046

Custom Anterior Surfacing of Scleral Lens for Vision Quality Improvement in Patients With Keratoconus

Phase: N/A

Role: Collaborator

Start: Oct 8, 2018

Completion: Jan 20, 2020

NCT04383015

Carbohydrate and Insulin Requirements During Prolonged Fasted Exercise

Phase: N/A

Role: Collaborator

Start: Oct 31, 2018

Completion: Oct 17, 2019

NCT03760913

OLP-1002 is Being Studied in the Treatment of Pain.

Phase: Early Phase 1

Role: Lead Sponsor

Start: Nov 21, 2018

Completion: Oct 16, 2020

NCT03374670

ZIMURA in Combination With Eylea in Patients With Idiopathic Polypoidal Choroidal Vasculopathy (IPCV)

Phase: Phase 2

Role: Lead Sponsor

Start: Nov 30, 2018

Completion: Dec 31, 2019

NCT03216460

Insulet Artificial Pancreas Free-Living IDE3

Phase: N/A

Role: Lead Sponsor

Start: Feb 4, 2019

Completion: May 28, 2019

NCT04055688

Novel Exoscope System for 5-ALA Fluorescence-Guided Surgery for Gliomas

Phase: N/A

Role: Collaborator

Start: Aug 15, 2019

Completion: Feb 23, 2021

NCT05447637

PROCLAIM: Germline Genetic Testing for Prostate Cancer Patients

Phase: N/A

Role: Lead Sponsor

Start: Nov 1, 2019

Completion: May 31, 2022

NCT04176731

Prepivotal Omnipod Horizon™ Automated Glucose Control System

Phase: N/A

Role: Lead Sponsor

Start: Dec 15, 2019

Completion: Jan 31, 2020

NCT03955744

3D Translabial Ultrasound for Pessary Size Estimation

Phase: N/A

Role: Collaborator

Start: Dec 18, 2019

Completion: Nov 17, 2023

NCT04196140

Pivotal Omnipod Horizon™ Automated Glucose Control System

Phase: N/A

Role: Lead Sponsor

Start: Dec 30, 2019

Completion: Apr 20, 2022

NCT04226378

Canadian Real-World Outcomes of Omnipod Initiation in People With T1D

Phase: N/A

Role: Collaborator

Start: Jan 20, 2020

Completion: Feb 9, 2020

NCT05359666

Retrospective Independent Safety Review of Closed Irrisept Study

Phase: N/A

Role: Lead Sponsor

Start: Mar 31, 2020

Completion: Nov 29, 2021

NCT04320069

Continuous Glucose Monitoring System (CGM)-Informed Bolus Calculator Study

Phase: N/A

Role: Lead Sponsor

Start: Jun 9, 2020

Completion: Sep 29, 2020

NCT04657783

French National Cohort of People With Type 1 Diabetes

Phase: N/A

Role: Collaborator

Start: Jun 10, 2020

Completion: Jun 10, 2035

NCT04657783

NCT04369885

Assessing Adherence to Home Telemedicine in Individuals With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A

Role: Collaborator

Start: Jul 1, 2020

Completion: May 24, 2021

NCT04349254

Observational Study of Vision Improvement in Late Stage Dry AMD Patients

Phase: N/A

Role: Lead Sponsor

Start: Aug 14, 2020

Completion: Dec 31, 2020

NCT04476472

Omnipod Horizon™ Automated Glucose Control System Preschool Cohort

Phase: N/A

Role: Lead Sponsor

Start: Sep 8, 2020

Completion: Oct 12, 2022

NCT04606030

LymphBridge: Surgical Evaluation for Breast Cancer-Associated Lymphedema (BioBridge)

Phase: N/A

Role: Lead Sponsor

Start: Oct 26, 2020

Completion: Dec 30, 2025

NCT04617795

Omnipod® 5 Automated Insulin Delivery System in Patients With Type 2 Diabetes

Phase: N/A

Role: Lead Sponsor

Start: Nov 23, 2020

Completion: Mar 6, 2022

NCT04678193

COVID-19 Risk Assessment for Hospitalization Outcomes and Epidemiology Efficacy

Phase: N/A

Role: Collaborator

Start: Dec 24, 2020

Completion: Jun 30, 2026

NCT05216341

Study of OLP-1002 Injections for Reducing Moderate to Severe Pain Due to Osteoarthritis in Hip and/or Knee Joint

Phase: Phase 2

Role: Lead Sponsor

Start: Jan 11, 2021

Completion: Sep 7, 2023

NCT04905160

Care Coordination to Assess Improvement in Outcomes in Hospital Readmissions

Phase: N/A

Role: Collaborator

Start: Feb 18, 2021

Completion: Dec 22, 2026

NCT04937244

Pilot Study Evaluating the Optimization of the ORBEYE Blue Light Filter During Fluorescence-Guided Resection of Gliomas

Phase: Phase 4

Role: Collaborator

Start: May 13, 2021

Completion: May 11, 2022

NCT06616519

A Study to Evaluate the Safety and Efficacy of MSENC1 Soft Hydrophilic Contact Lenses and Oxypure Color Soft Hydrophilic Contact Lenses

Phase: N/A

Role: Lead Sponsor

Start: May 18, 2021

Completion: Aug 25, 2022

NCT04714216

Automated Insulin Delivery for INpatients With DysGlycemia (AIDING) Feasibility

Phase: N/A

Role: Collaborator

Start: Jun 29, 2021

Completion: Aug 11, 2022

NCT06339190

Neurofilament Light Chain And Voice Acoustic Analyses In Dementia Diagnosis

Phase: N/A

Role: Collaborator

Start: Aug 1, 2021

Completion: Dec 31, 2027

NCT06339190

NCT05380557

ARTEMIS: Study of Patients With Early Stage Pancreatic Cancer Who Have Undergone Genetic Testing

Phase: N/A

Role: Lead Sponsor

Start: Aug 23, 2021

Completion: Sep 6, 2022

NCT04302259

Intelligent Spine Interface, Clinical (ISI-C)

Phase: N/A

Role: Collaborator

Start: Sep 1, 2021

Completion: Jun 30, 2025

NCT04693702

Observational Study of Vision Improvement in Patients With Retinal Disorders

Phase: N/A

Role: Lead Sponsor

Start: Oct 1, 2021

Completion: Mar 16, 2022

NCT05083728

S-32 PG 242 Short Stem

Phase: N/A

Role: Collaborator

Start: Nov 1, 2021

Completion: Jul 26, 2023

NCT05219734

MRD Assay Evaluates Recurrence and Response Via a Tumor Informed Assessment

Phase: N/A

Role: Lead Sponsor

Start: Nov 29, 2021

Completion: Dec 31, 2026

NCT04985266

A Trial of Early Detection of Molecular Relapse With Circulating Tumour DNA Tracking and Treatment With Palbociclib Plus Fulvestrant Versus Standard Endocrine Therapy in Patients With ER Positive HER2 Negative Breast Cancer

Phase: Phase 2

Role: Collaborator

Start: Mar 30, 2022

Completion: Sep 1, 2030

NCT04985266

NCT05877352

Intraoperative Electron Radiotherapy in Rectal Cancer - A Feasibility Trial

Phase: N/A

Role: Collaborator

Start: May 18, 2022

Completion: Jul 25, 2025

NCT05416710

Universal Germline Testing in the Community

Phase: N/A

Role: Lead Sponsor

Start: Jun 1, 2022

Completion: Jun 1, 2025

NCT05011942

Irrisept Spinal Fusion Pilot Study Protocol

Phase: N/A

Role: Collaborator

Start: Jun 6, 2022

Completion: Dec 31, 2024

NCT05409131

Omnipod 5 System Compared to Pump Therapy

Phase: N/A

Role: Lead Sponsor

Start: Jul 7, 2022

Completion: Jan 10, 2025

NCT06043921

Multicenter Study of Circulating Tumor DNA in Patients With Pancreatic Cancer Using a Personalized Panel

Phase: N/A

Role: Lead Sponsor

Start: Nov 1, 2022

Completion: Dec 31, 2026

NCT06616480

A Study to Evaluate the Safety and Efficacy of DSFNC1 Soft Hydrophilic Contact Lenses and SiHy Color Soft Hydrophilic Contact Lenses

Phase: N/A

Role: Lead Sponsor

Start: Mar 3, 2023

Completion: Jun 20, 2024

NCT05815342

OP5-005 Using Omnipod 5 in Adults With Type 2

Phase: N/A

Role: Lead Sponsor

Start: Apr 11, 2023

Completion: Mar 1, 2024

NCT06181721

Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes

Phase: N/A

Role: Lead Sponsor

Start: Sep 5, 2023

Completion: Jan 31, 2024

NCT05923827

Omnipod® 5 With Libre 2 vs. MDI for Type 1 Diabetes in Children and Adults

Phase: N/A

Role: Lead Sponsor

Start: Sep 11, 2023

Completion: Aug 8, 2025

NCT06144554

Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes

Phase: N/A

Role: Lead Sponsor

Start: Sep 25, 2023

Completion: Sep 30, 2027

NCT06024590

Outcomes of Irrisept Irrigation as an Adjunctive Treatment in the Management of Diabetic Foot Ulcers

Phase: N/A

Role: Collaborator

Start: Oct 3, 2023

Completion: May 22, 2025

NCT05695924

Surgical Evaluation for Upper Extremity Lymphedema (BioBridge)

Phase: N/A

Role: Lead Sponsor

Start: Nov 1, 2023

Completion: Dec 1, 2025

NCT04268836

Vision Improvement for Patients With Age-Related Macular Degeneration

Phase: N/A

Role: Lead Sponsor

Start: Jan 9, 2024

Completion: May 1, 2025

NCT04875234

Vision Improvement for Legally Blind Dry AMD Patients

Phase: N/A

Role: Lead Sponsor

Start: Jan 31, 2024

Completion: Dec 31, 2026

NCT06379919

Wound Irrigation Comparative Effectiveness Study

Phase: N/A

Role: Collaborator

Start: Mar 20, 2024

Completion: May 31, 2027

NCT06163469

Effect of Chlorhexidine Gluconate Bladder Instillations in Patients With Chronic Suprapubic Catheters on Unplanned Healthcare Encounters and Quality of Life

Phase: N/A

Role: Collaborator

Start: Apr 1, 2024

Completion: Dec 31, 2025

NCT06339203

Wound Irrigation With Saline Versus Hypodilute-chlorhexidine After Cesarean Section (WISHES Study)

Phase: N/A

Role: Collaborator

Start: Jun 5, 2024

Completion: Dec 31, 2026

NCT06547918

SmartAdjust 2.0 System With Type 1 and Type 2 Diabetes